Nektar announced positive results from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of its experimental drug, rezpegaldesleukin.
Stocktwits
Is Invesco RAFI US 1500 Small-Mid ETF (PRFZ) a Strong ETF Right Now?
Smart Beta ETF report for PRFZ
Zacks
Should Invesco RAFI US 1500 Small-Mid ETF (PRFZ) Be on Your Investing Radar?
Style Box ETF report for PRFZ
Zacks
Diana Shipping Announces Plans To Replace Six Directors At Genco In Proxy Fight
Diana Shipping said that a new board would give Genco an opportunity to explore strategic alternatives, including its own takeover offer.
Stocktwits
Diana Shipping Shares Rise After Hours– What’s With The Genco Rejection?
Diana said it has received a letter from the Genco’s Board rejecting its non-binding indicative proposal to acquire all of the issued and outstanding shares of Genco common stock not already owned by Diana.
Stocktwits
Alvotech’s Drug Approved In Europe As Biosimilar For Bone Disease Drug
AVT03 will be commercialised in Europe in partnerships with STADA Arzneimittel AG and Dr. Reddy’s, the company said.